Are there two sides to colorectal cancer?

International Journal of Cancer

Volumn 101, Issue 5, 2002, Pages 403-408

  Iacopetta, Barry ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Chemotherapy; Colon cancer; Distal colon; Epidemiology; Molecular profile; Proximal colon; Rectal cancer

Indexed keywords

FLUOROURACIL;

BIOCHEMISTRY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHROMOSOME ANALYSIS; CLINICAL TRIAL; COLON; COLORECTAL CARCINOMA; CPG ISLAND; DRUG SENSITIVITY; EMBRYOLOGY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; HEREDITY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MORPHOLOGY; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; RECTAL NEOPLASMS;

EID: 0037057510     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10635     Document Type: Short Survey

References (109)

1. A genetic model for colorectal tumorigenesis
2. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
3. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location
4. Trends in right and left-sided colon cancer
5. Hereditary cancers disclose a class of cancer genes
6. Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma
7. Multiple genetic alterations in distal and proximal colorectal cancer
8. Evidence for the existence of different types of large bowel tumor: Suggestions from the clinical data of a population-based registry
9. Two colons-two cancers? Proximal or distal adenocarcinoma: Arguments for a different carcinogenesis
10. Are right- and left-sided colon neoplasms distinct tumors?
11. Are there several colorectal cancers? Epidemiological data
12. Different mechanisms in the tumorigenesis of proximal and distal colon cancers
13. Dukes B colorectal cancer: Distinct genetic categories and clinical outcome based on proximal or distal tumor location
14. Comparison of mucosal microvasculature between the proximal and distal human colon
15. The microvascular structure of the normal colon in rats and humans
16. Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue
17. The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution
18. Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa. A histochemical study using lectins
19. Human large intestinal epithelium: Light microscopy, histochemistry, and ultrastructure
20. Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine
21. Regional proliferative patterns in the colon of patients at risk for hereditary nonpolyposis colorectal cancer
22. Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis
23. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas
24. Human right and left colon differ in epithelial cell apoptosis and in expression of Bak, a pro-apoptotic Bcl-2 homologue
25. Comparison of fermentation reactions in different regions of the human colon
26. Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites
27. Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel
28. No difference in stem cell somatic mutation between the background mucosa of right- and left-sided sporadic colorectal carcinomas
29. Bile acid metabolism by fresh human colonic contents: A comparison of caecal versus faecal samples
30. Cytochrome P450 activity and distribution in the human colon mucosa
31. Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects
32. Ornithine decarboxylase levels in patients with normal colonic mucosa
33. Intestinal distribution of human Na+/H+ exchanger isoforms NHE-1, NHE-2, and NHE-3 mRNA
34. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
35. Application of laser capture microdissection and proteomics in colon cancer
36. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia
37. Estimating the world cancer burden: Globocan 2000
38. Cancer of the large intestine: Epidemiologic findings
39. The distribution of cancer within the large bowel
40. Predictors of proximal vs distal colorectal cancers
41. A description of age, sex, and site distributions of colon carcinoma in three geographic areas
42. Changing distribution of primary cancers in the large bowel
43. Age and sex distribution of patients with colorectal cancer
44. Colorectal carcinomas: Diagnostic implications of their changing frequency and anatomic distribution
45. Subsite distribution and incidence of colorectal cancer in New Zealand, 1974-1983
46. Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry
47. Proximal shift of colorectal cancer in the Australian Capital Territory over 20 years
48. The Melbourne colorectal cancer study: Incidence findings by age, sex, site, migrants and religion
49. Diet and colon cancer: Integration of the descriptive, analytic, and metabolic epidemiology
50. Dietary intake and colon cancer: Sex- and anatomic site-specific associations
51. Carbohydrates and colorectal cancer risk among Chinese in North America Cancer
52. The influence of dairy and nondairy calcium on subsite large-bowel cancer risk
53. Calcium intake and risk of colon cancer in women and men
54. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study
55. Iron intake and the risk of colorectal cancer
56. Physical activity and risk of colorectal cancer in men and women
57. Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers
58. Subsite-specific risk factors for colorectal cancer: A hospital-based case-control study in Japan
59. Long-term tobacco smoking and colorectal cancer in a prospective cohort study
60. A meta-analysis of cholecystectomy and risk of colorectal cancer
61. Intestinal cancer after cholecystectomy: Is bile involved in carcinogenesis?
62. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma
63. Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis
64. Regional chemoprevention of carcinogen-induced tumors in rat colon
65. Chemopreventive efficacy of combined piroxicam and difluoromethylomithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos
66. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the nonsteroidal anti-inflammatory drug nabumetone
67. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
68. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite
69. The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women
70. Reproductive factors related to the risk of colorectal cancer by subsite: A case-control analysis
71. Postmenopausal hormone use and risk of large-bowel cancer
72. A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer
73. Menopause and colorectal cancer
74. Hormone replacement therapy and the risk of colorectal cancer: A meta-analysis
75. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
76. Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)
77. Polymorphisms and colorectal tumor risk
78. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?
79. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer
80. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability
81. Sporadic colorectal cancers with CpG island methylation: Clinicopathological features and relationship to microsatellite instability
82. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
83. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer
84. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors
85. Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk
86. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: Interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor
87. Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer
88. Aberrant crypt foci in patients with colorectal cancer
89. Differences in the expression of mucus-associated antigens between proximal and distal human colon adenocarcinomas
90. Proximal and distal cancers of the colon: 2 Epidemiologically different cancers
91. Human large-bowel cancer: Correlation of clinical and histopathological features with banded chromosomes
92. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas
93. EGF TGF-alpha, and EGF-R in human colorectal adenocarcinoma
94. Differential expression of cyclooxygenase 2 in human colorectal cancer
95. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors
96. Association of p53 mutations with short survival in colorectal cancer
97. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
98. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history
99. CpG island methylator phenotype in colorectal cancer
100. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer
101. Genetic instabilities in human cancers
102. Alternative genetic pathways in colorectal carcinogenesis
103. Towards a novel classification of human malignancies based on gene expression patterns
104. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
105. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
106. DNA microarrays in clinical oncology
107. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
108. Adjuvant 5FU plus levamisole in colonic or rectal cancer: Improved survival in stage II and III
109. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report